Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Fx Shoulder, Masimo, Tandem Diabetes Care.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cytosorbents, Cofactor Genomics, Todos Medical.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alibaba, Bactiguard, Co-Diagnostics, Convatec, Diasorin, Implandata, Insulet, Lucid Diagnostics, Neogenomics, Pavmed, The Technology Partnership Vigilenz, Vivalnk.

New hires and promotions in the med-tech industry, including: Alivecor, Optimizerx, Perkinelmer, Stryker.

Med-tech firms raising money in public or private financings, including: Biocept, Cn Bio Innovations, Dermtech.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Almirall, Athenex, Cerovene, Cyclo, Janssen, Lilly, Mallinckrodt, Meiragtx, Morphosys, Pfizer, Prevail, Sanofi, Takeda, Virpax.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acino, Astrazeneca, Atnahs, Azurrx, Bayer, Dynavax, Evqlv, Faron, GW, Hypera, Immunoprecise, Mateon, Ophirex, Sanofi, Sumitomo Dainippon, Takeda, Unum.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Albireo, Cytodyn, Evelo, Eyepoint, Galera, GW Pharmaceuticals, Karyopharm, Medivir, Merck, Orthotrophix, Urovant, VBI, Vivus.

Biopharmas raising money in public or private financings, including: AB Science, DBV, Enlivex, Evonetix, Marker, NLS, Oric, Passage Bio, Polyprox, Primmune, Theravance, Tonix, Vaxart, Verastem, Xilio.

Quarterly snapshots from biopharma companies with marketed products, including: Amicus.